Sept 30 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO ATL1102 FOR TREATMENT OF DMD
* POTENTIALLY ELIGIBLE FOR RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER
Sept 30 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* US FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO ATL1102 FOR TREATMENT OF DMD
* POTENTIALLY ELIGIBLE FOR RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER